
GlaxoSmithKline Pharmaceuticals Ltd
NSE:GLAXO

Cash Flow Statement
Cash Flow Statement
GlaxoSmithKline Pharmaceuticals Ltd
Mar-2020 | Sep-2020 | Mar-2021 | Sep-2021 | Mar-2022 | Sep-2022 | Mar-2023 | Sep-2023 | Mar-2024 | Sep-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | |||||||||||
Net Income |
6 473
|
6 251
|
7 231
|
8 213
|
7 675
|
7 553
|
8 374
|
8 739
|
9 598
|
10 855
|
|
Depreciation & Amortization |
827
|
0
|
793
|
0
|
682
|
0
|
658
|
0
|
697
|
0
|
|
Other Non-Cash Items |
(976)
|
0
|
(1 233)
|
0
|
(243)
|
0
|
(1 085)
|
(1 085)
|
(2 543)
|
(6 716)
|
|
Cash Taxes Paid |
1 859
|
0
|
1 470
|
0
|
1 205
|
0
|
2 647
|
0
|
2 542
|
0
|
|
Cash Interest Paid |
41
|
0
|
35
|
0
|
20
|
0
|
14
|
0
|
18
|
0
|
|
Change in Working Capital |
(1 418)
|
(682)
|
(1 012)
|
580
|
(6)
|
(3 860)
|
(3 105)
|
(1 422)
|
(1 932)
|
4 877
|
|
Cash from Operating Activities |
4 905
N/A
|
5 419
+10%
|
5 779
+7%
|
8 354
+45%
|
8 108
-3%
|
4 133
-49%
|
4 842
+17%
|
6 890
+42%
|
5 820
-16%
|
9 713
+67%
|
|
Investing Cash Flow | |||||||||||
Capital Expenditures |
(1 584)
|
0
|
(442)
|
0
|
(346)
|
0
|
(440)
|
0
|
(312)
|
0
|
|
Other Items |
1 015
|
3 402
|
4 628
|
1 852
|
(3 709)
|
6 237
|
8 519
|
(694)
|
399
|
(3 996)
|
|
Cash from Investing Activities |
(568)
N/A
|
1 819
N/A
|
4 186
+130%
|
1 410
-66%
|
(4 055)
N/A
|
5 890
N/A
|
8 079
+37%
|
(1 135)
N/A
|
87
N/A
|
(4 308)
N/A
|
|
Financing Cash Flow | |||||||||||
Net Issuance of Debt |
(151)
|
0
|
(150)
|
0
|
(156)
|
0
|
(169)
|
0
|
(181)
|
0
|
|
Cash Paid for Dividends |
(3 388)
|
0
|
(6 776)
|
0
|
(5 066)
|
0
|
(15 255)
|
0
|
(5 416)
|
0
|
|
Other |
(738)
|
(3 427)
|
(35)
|
1 664
|
(20)
|
(10 207)
|
(10)
|
9 851
|
(18)
|
(54)
|
|
Cash from Financing Activities |
(4 276)
N/A
|
(6 965)
-63%
|
(6 961)
+0%
|
(5 262)
+24%
|
(5 242)
+0%
|
(15 429)
-194%
|
(15 433)
0%
|
(5 573)
+64%
|
(5 615)
-1%
|
(5 651)
-1%
|
|
Change in Cash | |||||||||||
Net Change in Cash |
60
N/A
|
272
+351%
|
3 004
+1 003%
|
4 502
+50%
|
(1 190)
N/A
|
(5 406)
-354%
|
(2 512)
+54%
|
182
N/A
|
292
+61%
|
(246)
N/A
|
|
Free Cash Flow | |||||||||||
Free Cash Flow |
3 321
N/A
|
5 419
+63%
|
5 337
-2%
|
8 354
+57%
|
7 761
-7%
|
4 133
-47%
|
4 402
+7%
|
6 890
+57%
|
5 508
-20%
|
9 713
+76%
|